Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis

Clinical trial NCT00130637 · COMPLETED

Trial details

NCT number: NCT00130637
Sponsor: National Eye Institute (NEI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anterior Uveitis Arthritis, Juvenile Idiopathic Iritis Immunosuppression

Start date: 2005-08-01
Primary completion: 2008-05-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.